Table 5. Relationships between the regimens/cycles of adjuvant chemotherapy and survival outcomes in N3 population.
| Regimens | Survival rates | P | Cycles | Survival rates | P | |
|---|---|---|---|---|---|---|
| 4y OS | TPF | 89.3% | 0.157 | 1 | 85.2% | 0.580 |
| PF | 71.6% | 2 | 86.9% | |||
| GP | 86.8% | 3 | 81.8% | |||
| 4y DMFS | TPF | 79.3% | 0.592 | 1 | 82.1% | 0.892 |
| PF | 91.7% | 2 | 76.5% | |||
| GP | 76.5% | 3 | 84.6% | |||
| 4y LRFS | TPF | 92.7% | 0.162 | 1 | 88.2% | 0.245 |
| PF | 71.4% | 2 | 87.8% | |||
| GP | 86.5% | 3 | 80.8% | |||
| 4y DFS | TPF | 72.4% | 0.832 | 1 | 71.4% | 0.594 |
| PF | 64.3% | 2 | 65.2% | |||
| GP | 64.6% | 3 | 65.9% |
Abbreviations: OS = Overall Survival; DMFS = Distant Metastasis-Free Survival; LRFS = Locoregional Relapse-Free Survival; DFS = Disease-Free Survival.